Healthcare Business

Amarin will trial Vascepa as a COVID-19 treatment and that could more than offset investor concerns about patent litigation.
Chris Lange
Navidea Biopharmaceuticals shares more than doubled to close out the week after the company provided an update from its midstage study in patients with active rheumatoid arthritis.
Chris Lange
Amarin won FDA approval for its Vascepa cardiovascular disease drug in December but the pandemic and patent litigation are weighing on the stock.
Carl Sullivan
Arbutus Biopharma shares jumped on Tuesday after the company reported positive data from its early-stage clinical trial in patients with chronic hepatitis B virus infection.
Chris Lange
Sorrento Therapeutics shares jumped to start the week after the company announced that its COVID-19 antibody treatment had a positive showing.
Chris Lange
Moderna made a big step towards a COVID-19 vaccine early on Monday, and investors (and the stock market in general) responded very positively.
Chris Lange
Wedbush took a closer look at some of the companies in its coverage universe that are set to present at ASCO and what the impact may be going forward.
Chris Lange
AIM ImmunoTech shares ticked higher on Thursday after the company announced some big developments with the FDA concerning its treatment for cancer patients with COVID-19.
Chris Lange
Applied DNA Sciences shares made an incredible gain on Thursday after the company announced it had received an update from the FDA concerning its COVID-19 assay kit.
Chris Lange
There are still a lot of questions for Amarin must figure out before it gets back on track. For investors, the question is whether it is the market recovery that is lifting the stock instead of the...
Chris Lange
Novavax shares jumped on Tuesday after the company announced that it would be receiving a sizable investment to further produce its COVID-19 vaccine.
Chris Lange
CymaBay Therapeutics shares more than doubled on Tuesday after the company announced its first-quarter results, along with a corporate update.
Chris Lange
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Chris Lange
MyoKardia shares made an incredible gain on Monday after the company announced positive results from its late-stage pivotal clinical trial of mavacamten.
Chris Lange